|
|||
|
||||||
|
SPA Weekly Update July 14, 2006 NEWS/FUNDING OPPORTUNITIES
AROUND NYU-SOM IACUC – Coordinator Appointment We are pleased to announce the appointment of Ms. Sonnie Cheang as the IACUC Coordinator. Since 2004, Sonnie has been working in the Division of Laboratory Animal Resources, where she has gained knowledge and familiarity with many IACUC issues. She provided valuable help to the IACUC in the last few months by serving as the Interim Coordinator. The IACUC Office, which was recently incorporated into the Office of Sponsored Programs, is located in Greenberg Hall SC-2, Room 137. The telephone number of the Office is 212-263-5691 and the fax number is 212-263-0727. IACUC protocols may be submitted at the IACUC Office located in the Greenberg Hall or at the DLAR Office in MSB182. All IACUC protocol related inquiries should be directed to Ms. Cheang. You may also consult the IACUC website for meeting dates, protocol submission deadlines, answers to many questions, and details of standard procedures concerning animal experimentation at http://www.med.nyu.edu/dlar/iacuc/. IRB - Federal Wide Assurance Approved The Federal Wide Assurance (FWA) for NYU School
of Medicine IRB has been renewed and approved by the Office for
Human Research Protections (OHRP) through June 15th, 2009. The
approved FWA number is FWA00004952. If you conduct sponsored
research, you may need to provide this information to your sponsor.
Note: Funding agencies use this website to verify that an institution holds an active and approved OHRP FWA. NATIONAL INSTITUTES OF HEALTH Streamlined Review Process to be used for Ruth L. Kirschstein National Research Service Awards (NRSA) Postdoctoral Fellowship Applications (F32) Beginning with grant applications submitted for the August 5, 2006, receipt date, all study sections will use the NIH’s streamlined review process for the review of Ruth L. Kirschstein National Research Service Awards (NRSA) Postdoctoral Fellowship applications (F32). The streamlined review process allows reviewers more time to discuss applications likely to be supported. Reviewers will designate approximately 40% of the F32 applications as "non-competitive” which means they will not be scored. A designation of "non-competitive” requires unanimous agreement of the study section; if one reviewer disagrees, the application will be discussed by the review group. Reviewers will be instructed that the "non-competitive" designation is to be used for any application judged to be qualitatively in the lower 40% of F32 fellowship applications normally reviewed by that study section. As with all applications, those determined to be “non-competitive" will be reviewed and will receive summary statements with written critiques. “Non-competitive” applications will not receive full discussion at the study section meeting and thus will not have a "Resume and Summary of Discussion” paragraph. “Non-competitive" applications will not routinely be taken to the second level of review by the NIH Institutes and Centers. Please note that all Fellowship applications will be required to use the SF424 (R&R) form and Grants.gov for submission beginning August 5, 2007. For further information, please visit: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-06-077.html. NATIONAL OCEANIC AND ATMOSPHERIC ADMINISTRATION Announcements of Opportunity have been issued
to submit proposals to the National Oceanic and Atmospheric Administration,
Center for Sponsored Coastal Ocean Research/Coastal Ocean Program
under four different
The Federal Register Notice and full Announcement of Federal Funding Opportunity can be accessed through the NOAA Center for Sponsored Coastal Ocean Research/Coastal Ocean Program website.
Deadline: September
1, 2006 THE STONY WOLD – HERBET FUND, INC. Research Grants in Aid and Pulmonary Training Fellowships The Research Grant and Training Fellowship Program provides funding for the clinical investigation of respiratory diseases and promotes the training of teachers, scientific researchers, and clinicians in the pulmonary field. The Fund designates approximately $200,000 annually to support individual projects focusing on lung disease. Please note that funds are limited to the New York City Metro area (50 mile radius of NYC).
Formal application is due by October 15. Application forms and additional information is available at http://www.stonywold-herbertfund.com/. THE HEALTH EFFECTS INSTITUTE (HEI) Additional Health Effects Endpoints During the Chronic Bioassay This program solicits applications from scientists interested in measuring additional endpoints, such as vascular markers of inflammation and damage, genotoxicity, and immune responses. • Letters of Intent for are due on September
12, 2006 For more information, visit: http://www.healtheffects.org/. CHILDREN’S TUMOR FOUNDATION The Drug Discovery Initiative 2006 The goal of the Drug Discovery Initiative (DDI) is accelerate the search for effective treatments for neurofibromatosis by funding and facilitating early stage screening of candidate therapeutics for NF. DDI has two components:
For more information and application
packs, visit: http://www.ctf.org/professionals/ddi.htm. |
||||||
